KRED

Monday, May 15, 2017

Valeant Pharmaceuticals: Why One Bear is Staying Bearish

http://ift.tt/eA8V8J
Bronte Capital’s John Hempton explains why he’s not jumping on the Valeant Pharmaceuticals train.

May 15, 2017 at 08:12PM

http://ift.tt/2qJ7TQ8

from Ben Levisohn

http://ift.tt/2qJ7TQ8